MediPharm Labs Corp. (TSX: LABS)
Health Care · Pharmaceuticals · CA
CA$0.08
0.00% today · 0.0% 1Y
MediPharm Labs Corp. (TSX: LABS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $23.27M and employs 127 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.06 and 0.10.
Tweenvest scores MediPharm Labs Corp. across four factors: quality 48/100, value 62/100, growth 51/100. Its strongest factor is value.
LABS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $23.27M
- Revenue (TTM)
- $29.19M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.93
- 52-week high
- CA$0.10
- 52-week low
- CA$0.06
- Avg volume (3M)
- —
- Shares outstanding
- 427.18M
- Employees
- 127
- Next earnings
- —
About MediPharm Labs Corp.
MediPharm Labs Corp. operates as a pharmaceutical entity, specializing in the creation and global commercialization of premium, pharmaceutical-grade cannabis oils, concentrates, and sophisticated derivative products. Its market reach extends across Canada, Australia, Germany, and other international territories. The company manages the full cycle from developing and processing to packaging and distributing a diverse array of cannabis extracts and advanced cannabinoid-based formulations. Furthermore, MediPharm Labs provides auxiliary services including GMP-certified flower procurement, specialized packaging, and comprehensive logistics. This enterprise was established in 2015 and has its corporate headquarters situated in Barrie, Canada.
- ISIN
- CA58504D1006
- Founded
- 2015
- Listed since
- Mar 4, 2019
- Exchange
- The Toronto Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.